Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (245)	11/22/1997 5:43:00 PM
From: CYBERKEN	Read Replies (1) \| Respond to of 353

Holding a core of biotechs that are selling product or close to it is a lesson I learned as I went along also--and I think it will pan out. VD thread seems to be a good place for leads. At the same time I'm not about to completely abandon stocks that are doing extremely well in the earlier stages of research, PI, or early PII at the most. They still have an important place in any biotech portfolio, even though their high risk and wide swings necessitate a limited %. It's just a bad idea to keep them out-because the science changes rapidly, the better ones often have very shrewed management, and the eventual good fortune in the sector (a probable reality no matter how many times it's been stated) will undoubtedly increase the market premium for this long-range potential, which has lagged for a good year and a half. That said, I guess we've both been hit by stocks that are still far off from a marketable product. I know this is the crappiest time to say it's a learning experience-but I'm a much wiser investor because of it. I still don't want to be missing when this type of stock has it's day.

To: Andrew H who wrote (245)	11/22/1997 9:19:00 PM
From: j.d.robbins	Read Replies (1) \| Respond to of 353

Andrew, Do you know of any place on the net that I can get a list of biotech. stocks in p3 thanks j.d.